Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation

BACKGROUND: The combination of gemcitabine and docetaxel is often used to treat patients with recurrent sarcoma. Nab-paclitaxel is a taxane modified to improve drug exposure and increase intratumoral accumulation and, in combination with gemcitabine, is standard therapy for pancreatic cancer. Applyi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Blood Cancer
Päätekijät: Oesterheld, Javier E., Reed, Damon R., Setty, Bhuvana A., Isakoff, Michael S., Thompson, Patrick, Yin, Hong, Hayashi, Masanori, Loeb, David M., Smith, Tiffany, Makanji, Rikesh, Fridley, Brooke L., Wagner, Lars M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771264/
https://ncbi.nlm.nih.gov/pubmed/32386107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.28370
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia